Apical docation of the ubiquitous transport enzyme Na,K-ATPase has been implicated as a feature of cyst development in in vitro studies of human polycystic kidney disease (PKD) epithelia. We undertook an immunohistochemical study of murine gluamrticoid-iuduced PKD, the pcy mouse, the cpk mouse, and the diphenylthiazole (DPT)-indud rat models of PKD to determine if this feature was common to these models of cyst development. Distribution of Na,K-ATPase was determined with a polyclonal anti-Na,K-ATPase antibody and a nickel-silver-enhanced peroxidase color development system. Results were documented objectively with densitometric techniques. Control animals appropriate to the age, strain, and species of the experimental groups demonstrated the expected polar distribution of Na,K-ATF'ase to the basolateral surface. This distribution was more marked in mature animals. Tubular dilatation and cystic change, however, were associated with increased apical Na,K-ATF'ase in all models. The murine models demonstrated d d basolateral staining for Na,K-ATPase compared with controls, although this was not a feature of the DPT tat model. Abnormal location of Na,K-ATPase is a shared feature of a variety of animal models and human PKD. This may contribute to abnormal fluid and electrolyte flux favoting cyst formation or may represent expression of a less &rentiated renal tubule epithelial phenotype. (JHisrochem Cgtochem
Introduction
Renal cyst formation in polycystic kidney disease (PKD) is believed to involve a combination of renal tubuler cell proliferation and changes in fluid and electrolyte transport that favour egress of fluid into the luminal cavity (1). The ubiquitous transport enzyme Na,K-ATPase is usually located in a polar distribution almost exclusively on the basolateral cell membrane in the renal tubule. Enzyme activity generates a gradient favoring sodium reabsorption from tubule fluid (2) . Recent studies in recessive and dominant PKD epithelia from human (3,4) and mouse (5.6) have implicated mislocation of this enzyme to the apical, or luminal, surface of the tubule cell in transmural electrolyte transport towards the cyst cavity.
Difficulties in studying the evolution of PKD in humans at the cellular level have led to heavy emphasis on the study of animal models. The validity of this approach is limited by the ability of any given model to reproduce the observed features of human disease. For this reason, we undertook a densitometric immunohistochemical study of Na,K-ATPase location in four important animal models of PKD: glucocorticoid-induced PKD (GIPKD) in the neonatal mouse (7), the cpk (8) and pcy (9) mouse mutants, and diphenylthiazole-induced (DlT) PKD in the rat (10). These models were studied to test the hypothesis that mislocation of renal tubule Na,K-ATPase is a common feature of different models of PKD.
Materials and Methods
C3H mice and Sprague-Dawley rats used in the GIPKD and DFT models, respectively, were obtained from University of Manitoba stock bred from animals originally obtained from Charles River Biobreeding, Quebec. The C57BLbJ-cpk animals came from a colony maintained at Izaak Walton Killam Hospital for Children (Halifax, Nova Scotia, Canada) . The DBAIZFGpcy animals were from a colony maintained by the Department of Nutritional Sciences, University of Guelph (Guelph. Ontario, Canada) which were bred from stock from Fujita Health University (Toyoake, Aichi, Japan). All animal procedures were approved by local committees on Animal Use as being within the guidelines of the Canadian Council on Animal Care.
A polyclonal rabbit anti-Na,K-ATpax raised against enzymatically denatured rabbit Na,K-ATPase and pre-immune control rabbit senun were pur-785 786 OGBORN, SAREEN, TOMOBE, TAKAHASHI, CROCKER chased from Easracres Biologicals (Springfield, MA). This antibody had an endpoint dilution of 1:800 in an ELISA against 1 pglml undegraded rabbit renal Na,K-ATPase holoenzyme and was the same product used in a previously published study (6). Assay information based on reaction with enzyme subunits is not available. Secondary antibodies, color development reagents. and other chemicals were purchased from Sigma (Sr Louis, MO). DF'T was purchased from Baxter Health Care (Round Lake. IL). Methylprednisolone acetate (MPA) was purchased from Upjohn (Don Mills, Ontario. Canada).
GIPKD was produced by a 200 mglkg IM injection of MPA into the hind leg of neonatal C3H mice as previously described (7). Saline injection animals served as controls. These animals were killed at 3 days of age and kidneys hammed for study. DPTwas fed to 150-175-g male Sprague-Dawley rats as a 1% mixture in pelleted rat chow for 28 days to induce this form of PKD (IO). Control rats were fed 10 gll00 g body weighrlday of the same rat chow. Kidneys from cpk animals were harvested at 21 days in Halifax, Nova Scotia, snap-frozen in liquid nitrogen. and sent on dry ice to the immunohistochemistry laboratory in Winnipeg, Manitoba. A similar procedure was observed for 5-month-old pcy animals raised at the University of Guelph. Preliminary studies on snap-frozen and fresh adult mouse renal tissue demonstrated that freezing in this fashion did not influence anti-Na,K-ATPase staining by the protocol described below.
After harvest or removal from the freezer, tissue was placed in 3.5% paraformaldehyde for 15 min. then embedded in Immunobed (Polyxiences:
Warrington. PA) using the monomer solution as a dehydrating agent. We and others have previously found that detection of Na.K-ATPase in tissue embedded in this medium is very sensitive to fixation conditions and the above regimen was found to give best results (5.6). After polymerization. 1.5-pm sections were cut. Staining for Na.K-ATPase was by adaptation of our previously published methods (6). Sections were etched with 0.75% NaOH in ethanol for 10 min. trypsinized with 0.4% trypsin in 0.02% CaC12 for 30 min at 37'C. then washed in H20 and 5% goat serum applied as a blocking agent. After repeat washing 1:5 dilution of primary antibody or pre-immune rabbit serum was applied overnight at 4°C. Secondary antibody (1:80) was then applied at room temperature for 2 hr. followed by peroxidase-anti-peroxidase complex. M e r a IO-min application of 0.050/0 diaminobenzidine with 0.07% NiC12 with 0.01% HzOz and washing. the slides were covered in glycerinated gelatin for 2 hr to minimize background staining. Staining was then enhanced with silver development according to the methods of Frigo et al. (11) . The duration of all steps and the concentrations of reagents were identical for all tissues studied. In addition to the pre-immune rabbit serum controls. sections in which primary antibody, secondary antibody. or peroxidase-anti-peroxidase complex were omitted were processed concurrently and used as negative controls. Selected sections were also stained with an FIT-conjugated secondary antibody and observed under ultraviolet light to confirm that observed peroxidase activity was not due to residual endogenous enzyme.
Image analysis was performed using ImageMeasure sofrware (Phoenix Biotechnology; Seattle, WA) applied to a high-resolution black-and-white video image captured from a microscope by a Cohu high-resolution camera interfaced to a computer via a PC Visionplus board using our previously published techniques (6). A loo-pixel window was placed over 100 apical and 100 basolateral cell surfaces of tubules selected by random cursor movement within a x 355 magnification screen image of each section.
Using the densitometry-fluorometry module (IM4100) of the program, the area of this window that was beyond the staining threshold was reported as a percentage of the total window. This window size COVCK approximately one third of the depth of cystic epithelium. Statistical analysis was performed by one-way analysis of variance on a data set containing all individual densitometric measurements with the Tukey procedure for post hoc comparisons using the Sysrat statistics package (Sysrar; Evanston, IL) (12).
Results
Saline-injected C3H animals (n = 2). adult DBA animals without the pcy mutation (n = 2). and normal male Sprague-Dawley rats (n = 3, demonstrated positive for Na*K-ATPase in the expected distribution. There was a preponderance of staining on the basolateral surface and less staining on the apical or tubular luminal surface (Figures la and 2a ). AS has been previously de-788 scribed (13), this polarization was less marked in suckling 3-dayold C3H mice that received an injection of 0.09% saline.
Apical staining for Na.K-ATPase was seen to a variable extent in all the animal models (Figures lb-ld and 2b) . The GIPKD (n = 4) and cpk (n = 4) models were both associated with a marked reversal of polarity, with visibly stronger staining on the apical surface. The pcy (n = 5) and DFT (n = 3) models demonstrated a loss of distinction between apical and basolateral staining that was seen in control animals. The contrast between apical and basolateral staining is shown in high-power magnification from control and DPT-treated rats in Figure 3 .
Densitometric analysis confirmed the visual findings in both mouse (Figure 4) and rat ( Figure 5 ) models. Apical staining density was significantly greater in affected animals than age-and species-appropriate controls at thepCOOl level in all but the cpk model. In all the mouse models of PKD, but not in the DFT model, basolateral staining was significantly reduced compared with appropriate controls (p<O.OOl) and was significantly less than apical staining in the same samples (p<O.OOl).
Discussion
Previous studies that have implicated the activity of Na,K-ATPase in renal cyst formation have followed two lines of evidence. Avner et al. (14) have demonstrated increased Na,K-ATPase activity in in OGBORN, SAREEN, TOMOBE, TAKAHASHI. CROCKER vitro preparations from homozygous cpk mouse. We have previously found a significant relationship in vivo between renal tubule luminal volume and Na,K-ATPase activity in GIPKD in the C3H mouse (15). Avner et al. (16) were able to eliminate cyst formation with ouabain in glucocorticoid-and tri-iodothyronine-induced models. Grantham et al. (17) were similarly able to eliminate cyst cavitation, although not cell proliferation, with ouabain treatment in the MDCK-collagen gel model. The other line of evidence, supported by this report, relies on histological studies of Na,K-ATF'ase location within cyst epithelia. Wilson et al. (4) have demonstrated apical mislocation of Na,K-ATPase to the apical surface of epithelial cells cultured from an ADPKD patient. This finding was supported by inhibition of sodium transport by selective apical application of ouabain. A similar mislocation has been reported in an autopsy renal specimen from an infant with autosomal recessive PKD (3). Our results corroborate the previous report of apical Na,K-ATPase mislocation in the cpk mouse by Avner et al. ( 5 ) . Carone et al. (18) . however. have recently reported no evidence of apical mislocation in the DPT model. That study, however, described only events very early in the development of this model, whereas our study involved animals with advanced disease. The ontogeny of this shift in Na,K-ATPase location merits further study. Our study does not differentiate whether the increased staining represents an increase in density of Na,K-ATPase units or an increase in membrane area bearing such units. Previous reports of cyst ultrastructure (1) favor the former explanation.
Apically located Na,K-ATPase has been reported as a normal feature of differentiating renal tubules (13). The observed mislocation may therefore represent a feature associated with cyst development, "development arrest" of cells at an immature and actively proliferating stage as proposed by Rankin et al. (19) . In our GIPKD preparations, however, which still contain an actively differentiating metanephric rim, the Na,K-ATPase staining in the metanephros was an order of magnitude less than in the deeper tissues. This implies that although there may be qualitative similarities in Na,K-ATPase distribution between cystic tubules and immature tubules, quantitative differences remain to be explained. Wilson Hammerton et al. @), using an in vitro model based on MDCK cells, have demonstrated that apical Na,K-ATPase is rapidly inactivated and lost from the cell membrane after cell-cell contact. This suggests that the persistence of apical Na,K-ATPase in the various advanced cystic epithelia that we have studied is not simply a marker of a rapidly developing epithelium. Previous studies have implicated changes in basement membrane and tubule compliance, renal tubule cell hyperplasia, and changes in electrolyte transport in cyst formation (1). These factors are clearly not mutually exclusive. Our report suggests that location of Na,K-ATPase in a location favoring electrolyte secretion may be part of a final common pathway of cyst formation, although further studies to explore the functional status of the enzyme are indicated. The concept that Na,K-ATPase-driven Na+ transport is integral to cyst formation has been strongly contested by evidence from in vitro models that AMP-dependent CI-transport is involved (21). The ubiquitous nature of both pathways may limit the application to therapeutic maneuvers. The identification of features shared by human disease, however, strengthens the validity of studying these diverse animal models of PKD.
